Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Eton Pharmaceuticals, Inc. ETON
$3.55
+$0.08 (2.31%)
На 18:01, 12 мая 2023
+153.52%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
89775488.00000000
-
week52high
4.25
-
week52low
1.95
-
Revenue
21251000
-
P/E TTM
-9
-
Beta
1.44923300
-
EPS
-0.39000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 25 июл 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 22 мар 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 17 мар 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 04 янв 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 30 сент 2020 г. |
| HC Wainwright & Co. | Buy | Buy | 26 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BRYNJELSEN SEAN | A | 1040000 | 10000 | 22 сент 2022 г. |
| BRYNJELSEN SEAN | A | 110000 | 110000 | 12 июл 2022 г. |
| Gruber James R. | A | 40000 | 40000 | 12 июл 2022 г. |
| CASAMENTO CHARLES J | A | 109555 | 50000 | 07 февр 2022 г. |
| Troutman William Wilson | A | 671200 | 15000 | 07 февр 2022 г. |
| MAIER PAUL V | A | 109555 | 50000 | 07 февр 2022 г. |
| Adams Jennifer McKie | A | 78133 | 50000 | 07 февр 2022 г. |
| RIEDEL NORBERT G | A | 109555 | 50000 | 07 февр 2022 г. |
| BRYNJELSEN SEAN | A | 1601500 | 416500 | 07 февр 2022 г. |
| Opaleye Management Inc. | D | 2375000 | 25000 | 17 ноя 2021 г. |
Новостная лента
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
11 мая 2023 г. в 19:02
Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.21 per share a year ago.
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
GlobeNewsWire
03 мая 2023 г. в 16:05
DEER PARK, Ill., May 03, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2023 financial results on Thursday, May 11, 2023. Management will host a conference call and live audio webcast to discuss these results at 4:30 p.m. ET (3:30 p.m. CT).
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Surpass Estimates
Zacks Investment Research
16 мар 2023 г. в 19:05
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 300% and 6.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
GlobeNewsWire
07 мар 2023 г. в 16:05
DEER PARK, Ill., March 07, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report fourth quarter 2022 financial results on Thursday, March 16, 2023. Management will host a conference call and live audio webcast to discuss these results at 4:30 p.m. ET (3:30 p.m. CT).
Eton Pharmaceuticals, Inc. (ETON) Upgraded to Strong Buy: Here's What You Should Know
Zacks Investment Research
08 февр 2023 г. в 13:33
Eton Pharmaceuticals, Inc. (ETON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).